PRQR
Price
$2.16
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Capitalization
227.55M
97 days until earnings call
Intraday BUY SELL Signals
RNXT
Price
$0.97
Change
-$0.03 (-3.00%)
Updated
Nov 13 closing price
Capitalization
35.71M
138 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRQR vs RNXT

Header iconPRQR vs RNXT Comparison
Open Charts PRQR vs RNXTBanner chart's image
ProQR Therapeutics
Price$2.16
Change-$0.00 (-0.00%)
Volume$281.17K
Capitalization227.55M
RenovoRx
Price$0.97
Change-$0.03 (-3.00%)
Volume$606.67K
Capitalization35.71M
PRQR vs RNXT Comparison Chart in %
PRQR
Daily Signal:
Gain/Loss:
RNXT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRQR vs. RNXT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRQR is a Hold and RNXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (PRQR: $2.16 vs. RNXT: $0.97)
Brand notoriety: PRQR and RNXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRQR: 57% vs. RNXT: 100%
Market capitalization -- PRQR: $227.55M vs. RNXT: $35.71M
PRQR [@Biotechnology] is valued at $227.55M. RNXT’s [@Biotechnology] market capitalization is $35.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRQR’s FA Score shows that 1 FA rating(s) are green whileRNXT’s FA Score has 0 green FA rating(s).

  • PRQR’s FA Score: 1 green, 4 red.
  • RNXT’s FA Score: 0 green, 5 red.
According to our system of comparison, PRQR is a better buy in the long-term than RNXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRQR’s TA Score shows that 4 TA indicator(s) are bullish while RNXT’s TA Score has 3 bullish TA indicator(s).

  • PRQR’s TA Score: 4 bullish, 6 bearish.
  • RNXT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both PRQR and RNXT are a bad buy in the short-term.

Price Growth

PRQR (@Biotechnology) experienced а -2.26% price change this week, while RNXT (@Biotechnology) price change was +0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

PRQR is expected to report earnings on Feb 19, 2026.

RNXT is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($228M) has a higher market cap than RNXT($35.7M). PRQR YTD gains are higher at: -18.491 vs. RNXT (-22.481). RNXT has higher annual earnings (EBITDA): -11.25M vs. PRQR (-35.56M). PRQR has more cash in the bank: 120M vs. RNXT (12.3M). RNXT has less debt than PRQR: RNXT (260K) vs PRQR (16.9M). PRQR has higher revenues than RNXT: PRQR (16.5M) vs RNXT (662K).
PRQRRNXTPRQR / RNXT
Capitalization228M35.7M639%
EBITDA-35.56M-11.25M316%
Gain YTD-18.491-22.48182%
P/E RatioN/AN/A-
Revenue16.5M662K2,492%
Total Cash120M12.3M976%
Total Debt16.9M260K6,500%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRQRRNXT
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PRQR
Daily Signal:
Gain/Loss:
RNXT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLK1093.938.17
+0.75%
Blackrock
BXSL26.770.12
+0.45%
Blackstone Secured Lending Fund
AVBH25.07-0.23
-0.91%
Avidbank Holdings Inc
GSIW0.16-0.01
-3.81%
Garden Stage Limited
SLDP6.67-0.43
-6.06%
Solid Power

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
N/A
RGNX - PRQR
46%
Loosely correlated
+0.43%
BEAM - PRQR
45%
Loosely correlated
-2.71%
ETHZ - PRQR
44%
Loosely correlated
+0.89%
SYRE - PRQR
43%
Loosely correlated
+0.34%
ENVB - PRQR
43%
Loosely correlated
+0.67%
More

RNXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNXT has been loosely correlated with CYTK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if RNXT jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-6.54%
CYTK - RNXT
33%
Loosely correlated
-0.84%
TARA - RNXT
32%
Poorly correlated
-1.12%
GNPX - RNXT
30%
Poorly correlated
+13.58%
SPRB - RNXT
29%
Poorly correlated
-9.29%
PRQR - RNXT
28%
Poorly correlated
N/A
More